indie Semiconductor, Inc.
INDI Nasdaq Semiconductors & Related Devices Financials FY2020–FY2025
Last close · Oct 23, 2026
$1.63
3.0%What indie Semiconductor, Inc. does
No business description yet.
- Legal name
- indie Semiconductor, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Feb 27, 2026
- Accession · CIK
- 0001193125-26-082535
0001841925
Revenue and margins
indie Semiconductor, Inc. had $217M of revenue in fiscal 2025, up 0.3% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was −$71.4M in fiscal 2025, −32.9% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
indie Semiconductor, Inc. returned — to shareholders in fiscal 2025. The diluted share count rose 12.7%.
Balance sheet
Cash, debt and the ratios that show how comfortably indie Semiconductor, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $219M | $322M | $152M | $274M | $145M |
| Debt incl. finance leases | $6.4M | $171M | $165M | $394M | $367M |
| Debt / equity | 0.0x | 0.5x | 0.4x | 0.9x | 1.0x |
| Interest coverage | −60.4x | −70.4x | −15.7x | −18.4x | −8.7x |
| Current ratio | 7.4x | 5.8x | 2.0x | 4.8x | 3.7x |
| Quick ratio | 7.1x | 5.6x | 1.7x | 4.2x | 3.1x |
| Total assets | $469M | $603M | $819M | $941M | $841M |
| Total liabilities | $177M | $289M | $342M | $496M | $457M |
| Shareholders' equity | $313M | $313M | $446M | $418M | $358M |
| Net debt (− = net cash) | −$213M | −$150M | $13.3M | $119M | $222M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. “Plan” marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Net income is positive | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ |
| Cash from operations is positive | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ |
| Return on assets rose | — | ✓ | ✓ | ✕ | ✓ | ✕ |
| Cash from operations exceeds net income | ✓ | ✓ | ✕ | ✓ | ✓ | ✓ |
| Debt fell relative to assets | — | ✓ | ✕ | ✓ | ✕ | ✕ |
| Current ratio rose | — | ✓ | ✕ | ✕ | ✓ | ✕ |
| Share count didn't rise | — | ✕ | ✕ | ✕ | ✕ | ✕ |
| Gross margin rose | — | ✕ | ✓ | ✕ | ✓ | ✕ |
| Revenue rose relative to assets | — | ✕ | ✓ | ✓ | ✕ | ✓ |
| F-score | — / 3 | 4 / 9 | 3 / 9 | 3 / 9 | 4 / 9 | 2 / 9 |
| Accruals ratio | −217.2% | −12.8% | 6.2% | −1.9% | −8.4% | −9.6% |
| Altman Z'' | −35.98 | 2.39 | 1.86 | −0.11 | 0.22 | −1.25 |
6 years of figures
Amounts in USD. Hover a ratio’s name for its definition.
| Fiscal year | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Revenue | $22.6M | $48.4M | $111M | $223M | $217M | $217M |
| Gross profit | $9.6M | $19.7M | $50.3M | $89.6M | $90.3M | $86.6M |
| Research and development | $22.0M | $58.1M | $121M | $155M | $175M | $154M |
| Operating income | −$19.2M | −$74.8M | −$119M | −$135M | −$170M | −$154M |
| Interest expense | $2.2M | $1.2M | $1.7M | $8.7M | $9.3M | $17.6M |
| Pretax income | −$98.3M | −$119M | −$53.8M | −$133M | −$146M | −$154M |
| Income tax | $0.0M | −$0.3M | −$1.0M | −$4.5M | −$1.9M | −$3.0M |
| Net income | −$97.5M | −$88.0M | −$43.4M | −$118M | −$133M | −$143M |
| Net income to common | −$97.5M | −$88.0M | −$43.4M | −$118M | −$133M | −$143M |
| Diluted EPS | −$3.12 | −$1.26 | −$0.37 | −$0.81 | −$0.76 | −$0.73 |
| Diluted shares | 0.03B | 0.07B | 0.12B | 0.15B | 0.18B | 0.20B |
| Cash flow | ||||||
| Cash from operations | −$21.2M | −$55.8M | −$76.7M | −$104M | −$58.6M | −$57.1M |
| Capital expenditure | $0.6M | $2.7M | $7.6M | $12.8M | $14.3M | $14.3M |
| Free cash flow | −$21.9M | −$58.5M | −$84.3M | −$117M | −$72.9M | −$71.4M |
| Stock-based compensation | $0.0M | $22.9M | $41.9M | $43.7M | $67.2M | $65.1M |
| Acquisitions | $0.0M | $80.3M | $8.7M | $95.0M | $3.2M | $17.7M |
| Share buybacks | — | $0.0M | $7.4M | $0.0M | $0.0M | — |
| Dividends and buybacks | — | $0.0M | $7.4M | $0.0M | $0.0M | — |
| Balance sheet | ||||||
| Cash and short-term investments | $18.7M | $219M | $322M | $152M | $274M | $145M |
| Total debt | $12.8M | $6.4M | $171M | $165M | $394M | $367M |
| Current assets | $30.0M | $248M | $374M | $272M | $409M | $286M |
| Current liabilities | $122M | $33.7M | $64.0M | $139M | $84.9M | $76.5M |
| Inventory | $2.9M | $9.1M | $13.3M | $33.1M | $49.9M | $48.6M |
| Property and equipment, net | $2.2M | $11.1M | $15.8M | $27.0M | $34.3M | $43.3M |
| Goodwill | $1.7M | $114M | $136M | $295M | $266M | $293M |
| Intangible assets | $1.1M | $96.3M | $63.1M | $208M | $209M | $196M |
| Total assets | $35.1M | $469M | $603M | $819M | $941M | $841M |
| Total liabilities | $137M | $177M | $289M | $342M | $496M | $457M |
| Preferred stock | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | −$110M | $313M | $313M | $446M | $418M | $358M |
| Margins | ||||||
| Gross margin | 42.3% | 40.7% | 45.4% | 40.1% | 41.7% | 39.9% |
| Operating margin | −85.1% | −154.5% | −107.5% | −60.7% | −78.5% | −70.9% |
| Net margin | −431.2% | −181.9% | −39.2% | −52.7% | −61.2% | −65.8% |
| FCF margin | −96.7% | −120.8% | −76.1% | −52.5% | −33.7% | −32.9% |
| Returns | ||||||
| Return on capital | — | −58.9% | −57.9% | −23.3% | −25.0% | −21.0% |
| Return on capital employed | 22.1% | −17.2% | −22.1% | −19.9% | −19.9% | −20.2% |
| Return on equity | — | −86.9% | −13.9% | −31.0% | −30.7% | −36.9% |
| Return on assets | −277.6% | −34.9% | −8.1% | −16.5% | −15.1% | −16.1% |
| Return on tangible equity | — | −85.3% | −38.3% | — | — | — |
| Growth | ||||||
| Revenue growth | — | 114.1% | 128.9% | 101.4% | −2.9% | 0.3% |
| Share count change | — | 124.1% | 69.5% | 22.4% | 20.6% | 12.7% |
| Financial health | ||||||
| Debt / equity | — | 0.0x | 0.5x | 0.4x | 0.9x | 1.0x |
| Interest coverage | −8.8x | −60.4x | −70.4x | −15.7x | −18.4x | −8.7x |
| Current ratio | 0.2x | 7.4x | 5.8x | 2.0x | 4.8x | 3.7x |
| Quick ratio | 0.2x | 7.1x | 5.6x | 1.7x | 4.2x | 3.1x |
| Capital allocation | ||||||
| Capex / revenue | 2.8% | 5.5% | 6.8% | 5.7% | 6.6% | 6.6% |
| Stock comp / revenue | 0.0% | 47.3% | 37.8% | 19.6% | 31.0% | 29.9% |
| Quality scores | ||||||
| Piotroski F-score | — | 4.0 | 3.0 | 3.0 | 4.0 | 2.0 |
| Altman Z'' | −36.0 | 2.4 | 1.9 | −0.1 | 0.2 | −1.2 |
| Accruals ratio | −217.2% | −12.8% | 6.2% | −1.9% | −8.4% | −9.6% |
Source: SEC EDGAR XBRL filings (CIK 0001841925). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.
